Insider Transactions in Q2 2022 at Atri Cure, Inc. (ATRC)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+1.47%
|
$11,900
$34.73 P/Share
|
|
Jun 30
2022
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+1.41%
|
$11,900
$34.73 P/Share
|
|
Jun 30
2022
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+0.57%
|
$11,900
$34.73 P/Share
|
|
Jun 30
2022
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
350
+0.07%
|
$11,900
$34.73 P/Share
|
|
Jun 01
2022
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,900
+50.0%
|
-
|
|
May 25
2022
|
Mark A Collar Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+3.77%
|
-
|
|
May 25
2022
|
Deborah H Telman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+38.02%
|
-
|
|
May 25
2022
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+20.68%
|
-
|
|
May 25
2022
|
Regina E Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+15.26%
|
-
|
|
May 25
2022
|
Maggie Yuen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+38.02%
|
-
|
|
May 25
2022
|
Sven Wehrwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+16.53%
|
-
|
|
May 25
2022
|
Robert S. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+8.03%
|
-
|
|
May 25
2022
|
B Kristine Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+9.63%
|
-
|
|
May 13
2022
|
Tonya Austin Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
3,203
-15.38%
|
$134,526
$42.69 P/Share
|
|
Apr 08
2022
|
Tonya Austin Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
282
-1.34%
|
$17,202
$61.59 P/Share
|